{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:33:33Z","timestamp":1790667213399,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.aohep.2025.101938","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:06:41Z","timestamp":1750939601000},"page":"101938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chronic hepatitis B virus persistence: Mechanisms, consequences and implications for achieving cure"],"prefix":"10.1016","volume":"30","author":[{"given":"Christopher","family":"Georgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-8675","authenticated-orcid":false,"given":"Simmone","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Osiowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-3499","authenticated-orcid":false,"given":"Curtis L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0001","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.aohep.2025.101938_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17093293","article-title":"What is the role of the horizontal transmission of hepatitis B virus infection in young adult and middle-aged roma population living in the settlements in East Slovakia?","volume":"17","author":"Drazilova","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.aohep.2025.101938_bib0003","unstructured":"Hepatitis B. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed August 2."},{"key":"10.1016\/j.aohep.2025.101938_bib0004","unstructured":"Acute vs Chronic Hepatitis B. Available at: https:\/\/www.hepb.org\/what-is-hepatitis-b\/what-is-hepb\/acute-vs-chronic\/. Accessed October 15."},{"key":"10.1016\/j.aohep.2025.101938_bib0005","unstructured":"Cancer. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer. Accessed August 2."},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0006","doi-asserted-by":"crossref","first-page":"P516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/v13020210","article-title":"Hepatitis B Virus DNA integration and clonal expansion of hepatocytes in the chronically infected liver","volume":"13","author":"Mason","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0008","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2025.101938_bib0009","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3389\/fmicb.2018.02521","article-title":"Immunomodulatory function of HBeAg related to short-sighted evolution, transmissibility, and clinical manifestation of Hepatitis B virus","volume":"9","author":"Kramvis","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.aohep.2025.101938_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","article-title":"Role of HBx in hepatitis B virus persistence and its therapeutic implications","volume":"30","author":"Slagle","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"8","key":"10.1016\/j.aohep.2025.101938_bib0011","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cgh.2023.02.032","article-title":"New Perspectives on Development of Curative Strategies for Chronic Hepatitis B","volume":"21","author":"Feld","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2025.101938_bib0012","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/jvi.64.7.3319-3330.1990","article-title":"Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein","volume":"64","author":"Birnbaum","year":"1990","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.aohep.2025.101938_bib0013","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163175","article-title":"Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA","volume":"132","author":"Ghany","year":"2022","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.aohep.2025.101938_bib0014","doi-asserted-by":"crossref","first-page":"11652","DOI":"10.1073\/pnas.1635109100","article-title":"Hepatocyte turnover during resolution of a transient hepadnaviral infection","volume":"100","author":"Summers","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0015","article-title":"D e novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA","volume":"3","author":"Tu","year":"2021","journal-title":"JHEP Rep"},{"issue":"12","key":"10.1016\/j.aohep.2025.101938_bib0016","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of Hepatitis B virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/v16050764","article-title":"Intracellular host restriction of Hepatitis B virus replication","volume":"16","author":"Sinha","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.aohep.2025.101938_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fcell.2018.00154","article-title":"Host cell Rab GTPases in Hepatitis B virus infection","volume":"6","author":"Zeyen","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5009\/gnl240023","article-title":"Toward a functional cure for Hepatitis B","volume":"18","author":"Lok","year":"2024","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/v13020180","article-title":"Hepatitis B Virus DNA integration: in vitro models for investigating viral pathogenesis and persistence","volume":"13","author":"Tu","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.aohep.2025.101938_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02007-17","article-title":"Hepatitis B virus DNA integration occurs early in the viral life cycle in an in vitro infection model via sodium taurocholate cotransporting polypeptide-dependent uptake of enveloped virus particles","volume":"92","author":"Tu","year":"2018","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.aohep.2025.101938_bib0023","article-title":"Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells","volume":"4","author":"Tu","year":"2022","journal-title":"JHEP Rep"},{"issue":"5772","key":"10.1016\/j.aohep.2025.101938_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/286535a0","article-title":"Integration of hepatitis B virus sequences and their expression in a human hepatoma cell","volume":"286","author":"Edman","year":"1980","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3748\/wjg.v5.i4.289","article-title":"Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA","volume":"5","author":"Lee","year":"1999","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/jvi.37.1.239-243.1981","article-title":"Integration pattern of hepatitis B virus DNA sequences in human hepatoma cell lines","volume":"37","author":"Twist","year":"1981","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.aohep.2025.101938_bib0027","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/emboj\/20.12.3272","article-title":"Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection","volume":"20","author":"Li","year":"2001","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.aohep.2025.101938_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/genes9070365","article-title":"Cellular genomic sites of Hepatitis B virus DNA integration","volume":"9","author":"Budzinska","year":"2018","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29614","article-title":"Multi-omics panoramic analysis of HBV integration, transcriptional regulation, and epigenetic modifications in PLC\/PRF\/5 cell line","volume":"96","author":"Guan","year":"2024","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/v14020445","article-title":"Crosstalk between Hepatitis B virus and the 3D genome structure","volume":"14","author":"Dias","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.aohep.2025.101938_bib0031","article-title":"Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2025.101938_bib0032","unstructured":"Telomere. August 2, 2024 ed: National Human Genome Research Institute, 2024."},{"key":"10.1016\/j.aohep.2025.101938_bib0033","article-title":"Disparity landscapes of viral-induced structural variations in HCC: mechanistic characterization and functional implications","author":"Lyu","year":"2024","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.aohep.2025.101938_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02221-17","article-title":"Relative abundance of integrant-derived viral RNAs in infected tissues harvested from chronic Hepatitis B virus carriers","volume":"92","author":"Freitas","year":"2018","journal-title":"J Virol"},{"issue":"409","key":"10.1016\/j.aohep.2025.101938_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0036","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2021.04.051","article-title":"Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load","volume":"75","author":"Meier","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0037","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12967-024-05069-y","article-title":"HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma","volume":"22","author":"Jia","year":"2024","journal-title":"J Transl Med"},{"issue":"8022","key":"10.1016\/j.aohep.2025.101938_bib0038","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","article-title":"A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection","volume":"631","author":"Bosch","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0039","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158903","article-title":"Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells","volume":"133","author":"Nkongolo","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2025.101938_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-11-22","article-title":"Innate immune responses in hepatitis B virus (HBV) infection","volume":"11","author":"Busca","year":"2014","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0041","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus","volume":"126","author":"Op den Brouw","year":"2009","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2025.101938_bib0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-2-82","article-title":"Hepatitis B virus: inactive carriers","volume":"2","author":"Sharma","year":"2005","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.101938_bib0045","doi-asserted-by":"crossref","first-page":"m2200","DOI":"10.1136\/bmj.m2200","article-title":"Hepatitis B virus persistence and reactivation","volume":"370","author":"Shi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.aohep.2025.101938_bib0046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.micpath.2017.12.014","article-title":"HBV reactivation in rheumatic diseases patients under therapy: a meta-analysis","volume":"114","author":"Moghoofei","year":"2018","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0047","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0033-1345722","article-title":"Immunosuppression and HBV reactivation","volume":"33","author":"Shouval","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0048","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/hep.24529","article-title":"Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy","volume":"54","author":"Teng","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2025.101938_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/v9060139","article-title":"Detection of HBV covalently closed circular DNA","volume":"9","author":"Li","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.aohep.2025.101938_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-4027-2_9","article-title":"Detection of Hepatitis B virus covalently closed circular DNA and intermediates in its formation","volume":"2837","author":"Hong","year":"2024","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0051","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/geno.1995.9004","article-title":"A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome","volume":"29","author":"Minami","year":"1995","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.aohep.2025.101938_bib0052","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0166-0934(94)90142-2","article-title":"Inverse polymerase chain reaction for cloning cellular sequences adjacent to integrated hepatitis B virus DNA in hepatocellular carcinomas","volume":"49","author":"Tsuei","year":"1994","journal-title":"J Virol Methods"},{"key":"10.1016\/j.aohep.2025.101938_bib0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-6700-1_9","article-title":"Detection of hepatocyte clones containing integrated Hepatitis B virus DNA using inverse nested PCR","volume":"1540","author":"Tu","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.aohep.2025.101938_bib0054","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrg2841","article-title":"Advances in understanding cancer genomes through second-generation sequencing","volume":"11","author":"Meyerson","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.virs.2024.06.003","article-title":"Detection of HBV DNA integration in plasma cell-free DNA of different HBV diseases utilizing DNA capture strategy","volume":"39","author":"Yang","year":"2024","journal-title":"Virol Sin"},{"key":"10.1016\/j.aohep.2025.101938_bib0056","unstructured":"Short-Read Sequencing vs. Long-Read Sequencing: Which Technology is Right for Your Research? Available at:https:\/\/seqwell.com\/short-read-sequencing-vs-long-read-sequencing-which-technology-is-right-for-your-research\/. Accessed August 2."},{"issue":"19","key":"10.1016\/j.aohep.2025.101938_bib0057","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00299-21","article-title":"Targeted long-read sequencing reveals comprehensive architecture, burden, and transcriptional signatures from hepatitis B virus-associated integrations and translocations in hepatocellular carcinoma cell lines","volume":"95","author":"Ramirez","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.aohep.2025.101938_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B Virus DNA integration: Implications for diagnostics, therapy, and outcome","author":"Zoulim","year":"2024","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2025.101938_bib0059","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/apt.17670","article-title":"Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy","volume":"58","author":"Gao","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.aohep.2025.101938_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220376","article-title":"Genomic modeling of hepatitis B virus integration frequency in the human genome","volume":"14","author":"Podlaha","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2025.101938_bib0061","article-title":"Opportunities and challenges for hepatitis B cure","author":"Suarez","year":"2023","journal-title":"eGastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0062","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13099-021-00421-9","article-title":"Potential capacity of interferon-alpha to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus","volume":"13","author":"Wang","year":"2021","journal-title":"Gut Pathog"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0063","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41467-023-43078-5","article-title":"Interferon stimulated immune profile changes in a humanized mouse model of HBV infection","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.aohep.2025.101938_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/v14071393","article-title":"Drug discovery study aimed at a functional cure for HBV","volume":"14","author":"Watanabe","year":"2022","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.aohep.2025.101938_bib0065","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1093\/cid\/ciac383","article-title":"Effect of antiviral treatment on hepatitis B virus integration and hepatocyte clonal expansion","volume":"76","author":"Chow","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0066","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2021.12.286","article-title":"Inhibition of viral replication reduces transcriptionally active distinct hepatitis B virus integrations with implications on host gene dysregulation","volume":"162","author":"Hsu","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0067","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/hep.22884","article-title":"Hepatitis B virus DNA levels and outcomes in chronic hepatitis B","volume":"49","author":"Chen","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0068","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hep.29320","article-title":"The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B","volume":"66","author":"Papatheodoridis","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0069","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.50.4.443","article-title":"Combination therapy for hepatitis B","volume":"50","author":"Di Bisceglie","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"issue":"9865","key":"10.1016\/j.aohep.2025.101938_bib0071","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.aohep.2025.101938_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12030599","article-title":"RNA interference therapeutics for chronic Hepatitis B: progress, challenges, and future prospects","volume":"12","author":"Sneller","year":"2024","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.aohep.2025.101938_bib0073","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"Fung","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.aohep.2025.101938_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/v14092052","article-title":"Oligonucleotide-based therapies for chronic HBV infection: a primer on biochemistry, mechanisms and antiviral effects","volume":"14","author":"Vaillant","year":"2022","journal-title":"Viruses"},{"issue":"21","key":"10.1016\/j.aohep.2025.101938_bib0075","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMoa2210027","article-title":"Efficacy and safety of bepirovirsen in chronic hepatitis B infection","volume":"387","author":"Yuen","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2025.101938_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198191","article-title":"Development of an in vivo delivery system for CRISPR\/Cas9-mediated targeting of hepatitis B virus cccDNA","volume":"290","author":"Kayesh","year":"2020","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.aohep.2025.101938_bib0077","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2284286","article-title":"Engineered extracellular vesicles for delivering functional Cas9\/gRNA to eliminate hepatitis B virus cccDNA and integration","volume":"13","author":"Zeng","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.aohep.2025.101938_bib0078","doi-asserted-by":"crossref","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.aohep.2025.101938_bib0079","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.7150\/thno.18114","article-title":"The gRNA-miRNA-gRNA ternary cassette combining CRISPR\/Cas9 with RNAi approach strongly inhibits hepatitis B virus replication","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.aohep.2025.101938_bib0080","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","article-title":"Permanent inactivation of HBV genomes by CRISPR\/Cas9-mediated non-cleavage base editing","volume":"20","author":"Yang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"10.1016\/j.aohep.2025.101938_bib0081","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.aohep.2025.101938_bib0082","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/carcin\/bgs365","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients","volume":"34","author":"Hsieh","year":"2013","journal-title":"Carcinogenesis"},{"issue":"22","key":"10.1016\/j.aohep.2025.101938_bib0083","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMoa2405485","article-title":"Xalnesiran with or without an immunomodulator in chronic hepatitis B","volume":"391","author":"Hou","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.aohep.2025.101938_bib0084","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/1078-0432.CCR-10-1114","article-title":"Direct effects of type I interferons on cells of the immune system","volume":"17","author":"Hervas-Stubbs","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/j.gastro.2013.12.036","article-title":"Hepatic immune regulation and its involvement in viral hepatitis infection","volume":"146","author":"Knolle","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.aohep.2025.101938_bib0086","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1073\/pnas.91.9.3764","article-title":"Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice","volume":"91","author":"Guidotti","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0087","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11901-016-0315-9","article-title":"Future therapy for hepatitis B virus: role of immunomodulators","volume":"15","author":"Pham","year":"2016","journal-title":"Curr Hepatol Rep"},{"issue":"4","key":"10.1016\/j.aohep.2025.101938_bib0088","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1473-3099(22)00727-7","article-title":"TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial","volume":"23","author":"Yuen","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aohep.2025.101938_bib0089","article-title":"Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy","author":"Mon","year":"2024","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.101938_bib0090","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T09:34:24Z","timestamp":1764668064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1665268125001632"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101938","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic hepatitis B virus persistence: Mechanisms, consequences and implications for achieving cure","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101938"}}